With fewer add-ons to buy, value has to come from the practices already owned, and buyers will want to see it practice by practice.
Perspective — Health Care Provider Platforms

After the roll-up: what provider platforms must now prove, practice by practice

The acquisition playbook is running out of room. The platforms that sell well will be the ones that can show organic growth, and explain where it comes from.

Paul Karner, PhD · Horizon Data Partners · November 2026 · 7-minute read

851 → 105
Physician practice deals, 2021 vs. H1 2026
−33%
PE physician investment in 2025
−16.5 pts
Physician retention two years after a PE exit
1 — The Playbook Is Running Out of Room

From buying growth to building it

For a decade, the provider platform playbook rested on acquisition: buy independent practices at a modest multiple, combine them, and sell the combined earnings at a higher one. That playbook is running out of room. Physician practice deals fell from a peak of 851 in 2021 to 105 in the first half of 2026, according to PitchBook data, and McKinsey found that private equity investment in physician assets fell by a third in 2025.

For a sponsor or a CEO, the implication is direct. With fewer add-ons to buy, value has to come from the practices already owned, and buyers will want to see it practice by practice.

2 — Fewer Add-Ons, Tighter Rules

Several forces are slowing roll-ups at once

Bain points to labor shortages and reimbursement pressure from public and private payers. States are adding oversight. Several now review health care transactions, and Oregon has gone furthest: its 2025 law bars management services organizations from controlling physician hiring, schedules, compensation, coding, billing policies, and payer contracts, for new arrangements since January 2026 and for existing ones from 2029.

Deals still happen, and dental, dermatology, musculoskeletal, and vision practices remain active. But McKinsey finds sponsors favoring targeted add-ons, adjacencies, and operating leverage over broad new platforms.

3 — What Buyers Will Ask at Exit

A track record of organic growth

Bain’s 2026 health care private equity report names the new exit priorities: a track record of organic growth, repeatable playbooks for ancillaries and acquisitions, and a reputation as an employer of choice for clinicians. The buyer pool has also widened. Distributors such as Cardinal Health, Cencora, and McKesson have bought specialty platforms, and strategic buyers like these will examine organic performance closely.

A platform that cannot separate same-store growth from acquired growth will struggle to defend its value.

4 — Four Questions for Every Practice

The first matters most; the other three determine its answer

1
Is same-store growth real?

Headline growth can come from acquisitions, new-site ramps, added providers, or a shift in procedure mix. Each has a different value and durability.

2
Are schedules actually full?

An empty slot still carries provider, staff, and chair or room cost, and no-shows hide unused capacity.

3
Are providers as productive as the model assumed?

Visits, procedures, and revenue per provider hour, site by site.

4
Are providers and patients staying?

Recall and return visits for patients; retention for physicians, dentists, and advanced practice providers.

5 — Provider Retention Is a Value Risk

Physicians leave after the exit

The fourth question deserves particular attention. A study by Berquist, Klarnet, and Dafny in JAMA Health Forum followed physicians at practices that private equity owners sold between 2016 and 2018. Two years after the sale, those physicians were 16.5 percentage points less likely to remain at the practice than comparable physicians elsewhere, a drop of more than a quarter in retention. They did not retire; they moved, often to larger groups. The authors suggest that retention incentives from the first deal expire at exit, and that the next owner may push harder on margins.

For a platform heading toward a sale, physician stability is a leading indicator to track now, not a surprise to discover in diligence.

6 — Where AI Fits

Judge it at the practice level

AI tools for scheduling, intake, documentation, and revenue cycle are arriving in practices quickly, but they do not pay off equally everywhere. Tools that guide front-desk staff through intake and scheduling tend to help most where management is thin or turnover is high, which describes many recently acquired practices. Practices still being integrated generally benefit from guiding and offloading routine work before they attempt to redesign whole processes. In every case, the test is whether a tool moves capacity, show rates, or collections at the practice level, not whether it is in use.

Our View

Same-store growth is the question

The question that matters most is same-store growth, and specifically how a platform achieves it. The other three questions are its components: a practice grows organically by filling its schedules, raising provider productivity, and keeping its providers and patients. A platform that tracks headline growth without breaking it into those parts cannot tell which lever is working and which is failing, and buyers will ask.

Economics and Governed Data, Not Just Dashboards

None of these answers comes from a standard report

Each acquired practice arrives with its own practice management system, its own definitions of a visit, a new patient, and a provider, and its own approach to coding and billing. The first step is a governed data foundation: a semantic layer and a shared model of practices, providers, patients, and appointments that holds across every acquisition.

The second step is economics. That means decomposing growth into same-store, acquired, de novo, and mix components; estimating what no-shows and unfilled slots cost by site; and modeling which providers are at risk of leaving and what each departure would do to revenue. A dashboard is only the last step, the place where that work becomes visible to the people who act on it.

The same foundation also changes who can do the analysis. With clear data governance in place, defining who owns each data domain, who stewards its definitions and quality, and who maintains the systems as custodian, practice and regional leaders no longer have to queue every question behind IT. A well-built semantic layer, AI tools that work against it, and the right training let operations, revenue cycle, and finance teams build the analytics they need themselves, while IT concentrates on keeping systems reliable and available.

From Measurement to Action

Analytics tied to what the platform can do

Measurement is only the start. The analytics that pay off are the ones tied to actions the business can take. For a provider platform, those include:

Capacity
No-shows

Measure show rates, find what predicts a missed appointment, and score each upcoming appointment daily inside the practice management system, so front-desk staff can confirm, overbook, or fill the slot from a waitlist. We built a model of this kind for a PE-backed dental group; a pilot has shown promising early evidence.

Retention
Providers at risk

Measure turnover, identify what precedes departures, such as changes in compensation, schedule load, or the expiry of retention terms, and set thresholds that put at-risk providers on a list regional leaders review well before an exit.

Growth
Lagging practices

Decompose growth, find which practices are lagging and why, and direct operating attention, recruiting, or capacity to the practices where it will move results.

What Owners Should Measure Now

Six measures, once the data is governed

Growth decomposition. Same-store, acquired, de novo, and mix, by practice and acquisition cohort.
Schedule utilization and show rates. By site, provider, and appointment type, with daily risk scores that drive confirmation and scheduling.
Productivity per provider hour. Against the assumptions in the acquisition model.
Patient recall and return rates. By practice and service line.
Provider retention. With early indicators of flight risk for physicians, dentists, and advanced practice providers, and thresholds that trigger outreach, especially ahead of exit.
One set of definitions. The same meaning for visit, patient, provider, and revenue across every acquired practice.

The platforms that sell well in this market will not be the ones that bought the most practices. They will be the ones that can show, practice by practice, that what they own is growing, full, productive, and staffed by providers who stay.

This brief is updated quarterly as new data arrives. Next update expected February 2027. Horizon applies its economics expertise to deliver new insights like these to clients regularly through their client portals. Not yet a client? Get in touch to learn how you can plug in.
Ready When You Are

See where your same-store growth comes from

A short conversation is enough to see which of these measures your data can support today, and where the foundation needs work.

Operating Partners

An independent read on whether a platform’s organic growth story will hold up with buyers.

Compare Notes
CEOs and CFOs

One governed view of practices, providers, and patients, and the economics to grow same-store revenue.

Map the Growth